Predicting referral need for febrile children in low-resource community settings in South and Southeast Asia
Open Access
- 29 April 2026
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 32 (5) , 1907-1916
Abstract
In resource-constrained community settings, identifying which febrile children require referral remains a major unmet need. Current World Health Organization (WHO) danger signs have limited accuracy, resulting in missed severe illness and unnecessary referrals. Here we developed and validated clinical prediction models to support referral decisions using data from 3,405 children aged 1−59 months presenting with community-acquired acute febrile illnesses to seven hospitals across Bangladesh, Cambodia, Indonesia, Laos and Vietnam. Cambodian data were held out for external validation. The model using simple clinical parameters (sensitivity 74.7% (95% confidence interval (CI): 59.4−88.1); specificity 99.1% (95% CI: 97.7−99.7)) outperformed WHO criteria (sensitivity 55.5% (95% CI: 39.4−72.7); specificity 82.6% (95% CI: 77.1−87.6)) for identification of children at risk of severe disease (death or organ support within 2 days). Including either pulse oximetry or the host biomarker soluble TREM1 (sTREM1) increased sensitivity to 88.9% (95% CI: 76.7−97.8; pulse oximetry) and 89.2% (95% CI: 76.9−97.5; sTREM1), respectively. The pulse oximetry-based model achieved these gains with a threefold reduction in referral rates. These approaches appear cost-effective (pulse oximetry incremental cost effectiveness ratio (ICER) = $26.28; sTREM1 ICER = $196.46) and could improve triage for febrile illness in low-resource settings by enabling more accurate referral decisions. They warrant evaluation in community-based trials.Keywords
Funding Information
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Wellcome (219644/Z/19/Z)
- Médecins Sans Frontières
This publication has 85 references indexed in Scilit:
- Point-of-Care Measurement of Blood Lactate in Children Admitted With Febrile Illness to an African District HospitalClinical Infectious Diseases, 2011
- Dealing with low-incidence serious diseases in general practiceBritish Journal of General Practice, 2011
- Evaluation of procalcitonin and neopterin level in serum of patients with acute bacterial infection.2010
- The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian childrenCritical Care, 2010
- Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic reviewThe Lancet, 2010
- Pediatric Sepsis Guidelines: summary for resource-limited countriesIndian Journal of Critical Care Medicine, 2010
- Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosisJournal of Clinical Epidemiology, 2009
- Soluble Form of Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) as a Diagnostic Marker of Serious Bacterial Infection in Febrile Infants Less Than Three Months of AgeJapanese Journal of Infectious Diseases, 2008
- Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rashArchives of Disease in Childhood, 2002
- The Role of RANTES in Meningococcal DiseaseThe Journal of Infectious Diseases, 2000